Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND5 pseudogene 34 (MTND5P34) is a nuclear pseudogene in humans that shares sequence similarity with the functional mitochondrial ND5 gene[4][6]. ND5 normally encodes a subunit of Complex I in the mitochondrial respiratory chain, but pseudogenes like MTND5P34 are genomic segments that resemble functional genes but do not produce active proteins. These nuclear-located pseudogenes have accumulated mutations (including premature stop codons) that prevent the production of functional ND5 protein[5][6]. MTND5P34 is not known to have a biological function, nor is it involved in disease or considered a therapeutic target. Its presence is the consequence of mitochondrial DNA fragments being inserted into the nuclear genome ("NUMTs"), a well-described phenomenon[5][6]. MTND5P34 is a noncoding pseudogene with no established biological function or therapeutic/drug relevance[4][5][6]. It is not a valid therapeutic target.
None (not a druggable or functional gene/protein)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND5 pseudogene 34 (MTND5P34).